Valuation: Guided Therapeutics Inc

Market Cap 25.1M 22.1M 20.38M 19.06M 35.72M 2.37B 36.38M 245M 94.88M 1.17B 94.24M 92.19M 4.06B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 27.98M 24.63M 22.72M 21.25M 39.81M 2.64B 40.55M 273M 106M 1.3B 105M 103M 4.53B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Change 5-day change 1-year change 3-year change Capi.($)
+13.33%-.--% - - 25.1M
+4.87%+6.61%+21.72%-6.11% 183B
-0.33%-0.09%-23.18%+22.79% 142B
+5.53%+6.25%-4.36%-20.70% 134B
-2.50%-1.09%-57.30%-17.62% 66.08B
+3.12%+3.44%+18.21%-0.75% 51.63B
-1.45%-2.53%-28.55%-33.60% 43.38B
+3.92%+5.87%+11.89%+10.22% 37.18B
+3.35%+3.41%+6.45%+42.08% 36.25B
+1.82%+6.10%-9.86%-18.72% 29.51B
Average +3.17%-0.26%-7.22%-2.49% 80.33B
Weighted average by Cap. +2.54%-0.60%-4.99%-2.70%

Financials

2024 2025
Net sales 7K 6.16K 5.68K 5.32K 9.96K 660K 10.15K 68.31K 26.46K 325K 26.28K 25.71K 1.13M 767K 675K 623K 583K 1.09M 72.3M 1.11M 7.49M 2.9M 35.66M 2.88M 2.82M 124M
Net income -2.42M -2.13M -1.96M -1.84M -3.44M -228M -3.5M -23.59M -9.14M -112M -9.07M -8.88M -391M -3.2M -2.81M -2.6M -2.43M -4.55M -301M -4.63M -31.19M -12.08M -149M -12M -11.74M -517M
Net Debt 1.77M 1.56M 1.44M 1.35M 2.52M 167M 2.57M 17.28M 6.69M 82.35M 6.65M 6.51M 286M 2.88M 2.53M 2.34M 2.18M 4.09M 271M 4.17M 28.07M 10.87M 134M 10.8M 10.56M 465M
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-